Skip to content
DraconiticResearch
Search Sources API
194,164 studies31 sourcesUpdated 14 min ago
Peer-reviewedCC BY-NC-NDJournal of clinical tuberculosis and other mycobacterial diseases

Drivers of drug-resistant tuberculosis treatment initiation delay at three tertiary health facilities in Uganda: A mixed-methods study

  • Lydia Nakiyingi1
  • Herbert Kayonga1
  • Stella Zawedde-Muyanja2
  • Joseph Baluku3
  • Joseph Musaazi2
  • Susan Adakun3
  • Ivan Kimuli1
  • Harriet Mayanja-Kizza1
  • Willy Ssengooba4
  • William Worodria3
4 affiliations
  1. 1Department of Internal Medicine, Makerere University School of Medicine, Kampala, Uganda
  2. 2Infectious Disease Institute, Makerere University, Kampala, Uganda
  3. 3Pulmonology unit, Mulago National Referral Hospital, Kampala, Uganda
  4. 4Makerere University Biomedical Research Centre, Makerere University College of Health Sciences, Kampala, Uganda
Read full textPDFCite

Related

  1. Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Selected Facilities of O.R. Tambo District Municipality, Eastern Cape, South Africa: A Retrospective Cohort Study.
    Yanga Somjobo, Lindiwe Modest Faye, Mojisola Clara Hosu
    Epidemiologia (Basel, Switzerland)Peer-reviewedCC BYFull textInfectious diseaseEurope PMC
  2. High Initiation but Suboptimal Completion of Tuberculosis-Preventive Treatment Among People Living With HIV on Antiretroviral Therapy, Persistent Tuberculosis Incidence, and Programmatic Implications: Findings From a 2-Year Multicountry Cohort Study
    Open forum infectious diseasesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Treatment outcomes and post-treatment mortality among people with multidrug/rifampicin-resistant tuberculosis in Sierra Leone: a national cohort study
    Faye Greenwood, Rashidatu Fouad Kamara, Ronnie Harding +4
    The Lancet regional health. AfricaPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Extended self-efficacy theory to explain patients’ non-adherence to tuberculosis treatment in Mpumalanga healthcare facilities
    Harma Motsi, Bester Chimbo
    CurationisPeer-reviewedCC BYFull textGeneral medicineDOAJ
  5. Pretreatment Attrition, Treatment Delay and Treatment Outcome in Drug-Resistant Tuberculosis: A Mixed-Methods Cohort Study in Public and Private Hospitals in Indonesia
    F. Azzumar, A. F. Rhamadianti, E. Anugrapaksi +8
    medRxivPreprintCC BYFull textEpidemiology & public healthmedRxiv

Cite

BibTeXRIS
BibTeX
@article{nakiyingi2026drivers,
  title = {{Drivers of drug-resistant tuberculosis treatment initiation delay at three tertiary health facilities in Uganda: A mixed-methods study}},
  author = {Lydia Nakiyingi and Herbert Kayonga and Stella Zawedde-Muyanja and Joseph Baluku and Joseph Musaazi and Susan Adakun and Ivan Kimuli and Harriet Mayanja-Kizza and Willy Ssengooba and William Worodria},
  journal = {Journal of clinical tuberculosis and other mycobacterial diseases},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13654042},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Drivers of drug-resistant tuberculosis treatment initiation delay at three tertiary health facilities in Uganda: A mixed-methods study
AU  - Lydia Nakiyingi
AU  - Herbert Kayonga
AU  - Stella Zawedde-Muyanja
AU  - Joseph Baluku
AU  - Joseph Musaazi
AU  - Susan Adakun
AU  - Ivan Kimuli
AU  - Harriet Mayanja-Kizza
AU  - Willy Ssengooba
AU  - William Worodria
PY  - 2026
DA  - 2026/09/30
JO  - Journal of clinical tuberculosis and other mycobacterial diseases
UR  - https://europepmc.org/article/PMC/PMC13654042
SN  - 2405-5794
ER  -